(Q44654534)

5 December 2017

title

Reassessment of buprenorphine in conditioned place preference: temporal and pharmacological considerations (English)

1 reference

5 December 2017

1 reference

Thomas M. Tzschentke

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14615874

1 April 2024

language of work or name

1 reference

13 November 2003

1 reference

full work available at URL

5 December 2017

http://link.springer.com/content/pdf/10.1007/s00213-003-1626-4.pdf

file format

Portable Document Format

1 reference

Crossref

DOI

https://api.crossref.org/works/10.1007/S00213-003-1626-4

http://link.springer.com/article/10.1007/s00213-003-1626-4/fulltext.html

1 April 2024

1 reference

https://api.crossref.org/works/10.1007/S00213-003-1626-4

http://link.springer.com/content/pdf/10.1007/s00213-003-1626-4

1 April 2024

1 reference

Crossref

DOI

https://api.crossref.org/works/10.1007/S00213-003-1626-4

1 April 2024

1 reference

5 December 2017

volume

172

1 reference

5 December 2017

issue

1

1 reference

5 December 2017

page(s)

58-67

1 reference

https://scigraph.springernature.com/pub.10.1007/s00213-003-1626-4

5 December 2017

exact match

0 references

cites work

Limbic brain structures are important sites of kappa-opioid receptor-mediated actions in the rat: a [14C]-2-deoxyglucose study

1 reference

12 December 2020

In vivo receptor binding of the opiate partial agonist, buprenorphine, correlated with its agonistic and antagonistic actions

1 reference

12 December 2020

Measuring reward with the conditioned place preference paradigm: a comprehensive review of drug effects, recent progress and new issues

1 reference

12 December 2020

Disposition in the rat of buprenorphine administered parenterally and as a subcutaneous implant.

1 reference

12 December 2020

Abuse liability studies of opioid agonist-antagonists in humans

1 reference

12 December 2020

Differential mechanisms in the acquisition and expression of heroin-induced place preference.

1 reference

12 December 2020

Motivational properties of buprenorphine as assessed by place and taste conditioning in rats.

1 reference

12 December 2020

Effects of buprenorphine on the self-administration of cocaine by humans

1 reference

12 December 2020

Human pharmacology and abuse potential of the analgesic buprenorphine: a potential agent for treating narcotic addiction

1 reference

12 December 2020

Blockade of D-1 receptors by SCH 23390 antagonizes morphine- and amphetamine-induced place preference conditioning.

1 reference

12 December 2020

HS-599: a novel long acting opioid analgesic does not induce place-preference in rats

1 reference

12 December 2020

Motivational properties of kappa and mu opioid receptor agonists studied with place and taste preference conditioning

1 reference

12 December 2020

Clinical actions of fentanyl and buprenorphine. The significance of receptor binding.

1 reference

12 December 2020

Buprenorphine has potent kappa opioid receptor antagonist activity

1 reference

12 December 2020

Sensitization to repeated morphine injection in the rat: possible involvement of A10 dopamine neurons

1 reference

12 December 2020

Behavioral pharmacology of buprenorphine, with a focus on preclinical models of reward and addiction

1 reference

12 December 2020

Behavioral and neurochemical interactions between cocaine and buprenorphine: implications for the pharmacotherapy of cocaine abuse

1 reference

12 December 2020

Comparison of pharmacological activities of buprenorphine and norbuprenorphine: norbuprenorphine is a potent opioid agonist

1 reference

12 December 2020

Agonistic effects of the opioid buprenorphine on the nociceptin/OFQ receptor

1 reference

12 December 2020

Agonist and antagonist properties of buprenorphine, a new antinociceptive agent

1 reference

12 December 2020

Buprenorphine is an Antagonist at the ϰ Opioid Receptor

1 reference

12 December 2020

Differential effects of mu and kappa opioid systems on motivational processes

1 reference

12 December 2020

Thrice-weekly supervised dosing with the combination buprenorphine-naloxone tablet is preferred to daily supervised dosing by opioid-dependent humans

1 reference

12 December 2020

Dissociation of buprenorphine-induced locomotor sensitization and conditioned place preference in rats.

1 reference

12 December 2020

Behavioral effects of buprenorphine and diprenorphine under a multiple schedule of food presentation in squirrel monkeys.

1 reference

12 December 2020

Comparison of buprenorphine and methadone in the treatment of opioid dependence

1 reference

12 December 2020

Effects of infusion rate of intravenously administered morphine on physiological, psychomotor, and self-reported measures in humans

1 reference

12 December 2020

Increased running response to morphine in morphine-pretreated mice

1 reference

12 December 2020

Abuse potential of various opioid medications

1 reference

12 December 2020

Conditioned aversion after delay place conditioning with amphetamine.

1 reference

12 December 2020

Morphine-induced activation of A10 dopamine neurons in the rat

1 reference

12 December 2020

Buprenorphine: Characteristics of binding sites in the rat central nervous system

1 reference

12 December 2020

Kinetics of respiratory depression in rats induced by buprenorphine and its metabolite, norbuprenorphine.

1 reference

12 December 2020

Opioids excite dopamine neurons by hyperpolarization of local interneurons.

1 reference

12 December 2020

Clinical pharmacology of buprenorphine: ceiling effects at high doses

1 reference

12 December 2020

63Ni electron-capture gas chromatographic assay for buprenorphine and metabolites in human urine and feces

1 reference

12 December 2020

Characterization of opiates, neuroleptics, and synthetic analogs at ORL1 and opioid receptors

1 reference

12 December 2020

In vivo receptor binding of opioid drugs at the mu site

1 reference

12 December 2020

Comparative analysis of buprenorphine- and norbuprenorphine-induced analgesic effects based on pharmacokinetic-pharmacodynamic modeling

1 reference

12 December 2020

Respiratory effects of opioid full and partial agonists in rhesus monkeys.

1 reference

12 December 2020

1 reference

12 December 2020

Simple methodology of assessment of analgesics' addictive potential in mice

1 reference

12 December 2020

Nor-binaltorphimine: a potent and selective kappa-opioid receptor antagonist with long-lasting activity in vivo

1 reference

12 December 2020

Discriminative stimulus effects of reversible and irreversible opiate agonists: morphine, oxymorphazone and buprenorphine

1 reference

12 December 2020

Quantitative determination of buprenorphine and its active metabolite, norbuprenorphine, in human plasma by gas chromatography--chemical ionization mass spectrometry

1 reference

12 December 2020

Effects of buprenorphine/naloxone in opioid-dependent humans

1 reference

12 December 2020

Relative abuse liability of diazepam and oxazepam: behavioral and subjective dose effects.

1 reference

12 December 2020

Identifiers

DOI

1 reference

5 December 2017

1 reference